How Dietary-Derived Ligands Enhance Cancer Immunotherapy
Nutritional signals modulate checkpoint blockade efficacy
Modern immunotherapies such as PD-1/PD-L1 checkpoint inhibitors depend on robust anti-tumour T cell responses, yet many patients fail to respond. A new Nature Communications study examines how nutritional metabolites influence these responses. The authors focus on the Aryl Hydrocarbon Receptor (AhR), a transcription factor activated by tryptophan-derived indoles found in cruciferous vegetables and produced by the gut microbiota. In pre-clinical mouse models they compared a purified indole-poor diet to the same diet supplemented with indole-3-carbinol (I3C), a precursor of potent AhR ligands. Mice fed the I3C-supplemented diet (containing physiologic AhR agonists) responded dramatically better to anti-PD1 therapy, whereas those on the indole-poor diet exhibit diminished tumour control. These findings underscore how simple dietary modifications can affect the efficacy of immunotherapies.
Dietary AhR ligands restore CD8⁺ T cell fitness
The researchers found that diet-derived AhR ligands do not change the baseline composition of tumour-infiltrating immune cells but are essential for reinvigorating CD8⁺ T cells following anti-PD1 treatment. When mice received I3C with anti-PD1 therapy, there was a surge of proliferating (Ki-67⁺) CD8⁺ T cells and an increase in NK cell infiltration. By contrast, the indole-poor diet failed to boost these responses, leading to reduced tumour control. The absence of dietary AhR ligands compromised early responses to checkpoint blockade by impairing CD8⁺ T cell expansion and reducing NK cell recruitment. These differences were not due to altered antigen-specific T cell priming; instead they were linked to the reinvigoration of progenitor-exhausted CD8⁺ T cells, a population crucial for long-term tumour immunity.
Cell-intrinsic requirement for AhR in T cells
To determine which immune subsets require AhR, the authors analysed conditional knockout mice. AhR expression was high in monocytes and macrophages and present in CD8⁺ and CD4⁺ T cells within tumours. By generating mice lacking AhR specifically in NK cells or T cells, they demonstrated that AhR in T cells, but not NK cells, is critical for anti-PD1 efficacy. CD8⁺ T cells deficient in AhR failed to proliferate or produce effector molecules after treatment, whereas NK cell intrinsic AhR deficiency had minimal impact. These data suggest that AhR signalling licenses CD8⁺ T cells to respond to checkpoint blockade, likely by promoting transcriptional programs associated with progenitor-exhausted and effector CD8⁺ T cell subsets.
Mechanistic insights from single-cell transcriptomics
The team used single-cell RNA sequencing (scRNA-seq) and bulk RNA-seq to dissect the transcriptional programs underlying these phenomena. scRNA-seq of tumour-infiltrating T cells revealed clusters corresponding to stem-like, effector and exhausted CD8⁺ T cell states; dietary AhR ligands did not alter cluster composition at baseline, but enhanced the transition of progenitor-exhausted cells into reinvigorated effectors after anti-PD1 therapy. Bulk RNA-seq of sorted progenitor-exhausted CD8⁺ T cells from mice fed the I3C diet identified 236 genes up-regulated relative to AhR-deficient cells (e.g., Cx3cr1, Tcf7 and Gzmb), implicating metabolic and interferon-response pathways. These gene sets were enriched in responding human lung cancer patients, hinting at clinical relevance.
Norgen's Single Cell RNA Purification Kit enabled high-quality transcriptomic analysis
High-quality RNA isolation is vital for capturing subtle transcriptional differences in rare immune subsets. For RNA-seq of sorted progenitor-exhausted CD8⁺ T cells, the investigators extracted total RNA using Norgen Biotek's Single Cell RNA Purification Kit (Cat.# 51800). This kit isolates RNA, including microRNA, from as few as a single cell, providing the sensitivity needed for downstream cDNA generation and library construction. Its rapid workflow and low elution volume yielded intact RNA suitable for SMART-Seq cDNA synthesis and Illumina sequencing. By delivering high-purity RNA, the kit supported differential gene-expression analyses that uncovered AhR-dependent transcriptional programs. Researchers aiming to profile rare T cell populations or perform microRNA-sequencing in similar models can leverage this kit to ensure reproducible, high-quality results.
Implications for nutrition-immunotherapy synergy
This study reveals that physiological activation of AhR by food-derived ligands is a prerequisite for optimal anti-PD1 therapy. Supplementing diets with I3C or related compounds could enhance checkpoint blockade efficacy by supporting progenitor-exhausted CD8⁺ T cell reinvigoration and promoting NK cell recruitment. Conversely, diets lacking AhR ligands may blunt immunotherapy responses. Since many cruciferous vegetables (e.g., broccoli, cabbage, Brussels sprouts) are rich sources of I3C precursors, the findings offer a mechanistic basis for dietary interventions that complement immunotherapy.
Beyond nutrition, the work highlights the value of single-cell transcriptomics in understanding immune regulation. Reproducible results depend on robust nucleic-acid purification; thus, integrating reliable kits like Norgen's Single Cell RNA Purification Kit into workflows ensures high-quality data and supports discovery of novel biomarkers. Together, these insights will guide researchers and clinicians in designing diet-based strategies and molecular assays to boost the success of immune-checkpoint blockade.
Key Takeaways
| Insight | Evidence |
|---|---|
| Diet-derived AhR ligands, such as indole-3-carbinol, are required for optimal anti-PD1 therapy. | Mice fed diets supplemented with I3C exhibited enhanced tumour control and reinvigoration of progenitor-exhausted CD8⁺ T cells, whereas indole-poor diets blunted responses. |
| AhR acts on cells intrinsically in T cells to mediate checkpoint therapy. | Conditional knockout models showed that AhR expression in T cells, rather than NK cells, is necessary for anti-PD1 efficacy. |
| Lack of dietary AhR ligands impairs CD8⁺ T cell proliferation and NK cell recruitment after therapy. | Tumours from indole-poor diet-fed mice displayed fewer Ki-67⁺ CD8⁺ T cells and reduced NK cell infiltration following anti-PD1 treatment. |
| High-quality RNA isolation enables detection of AhR-dependent gene programs. | Researchers isolated total RNA from sorted progenitor-exhausted CD8⁺ T cells using Norgen's Single Cell RNA Purification Kit, ensuring high integrity for downstream RNA-seq. |
| Dietary interventions could complement immune-checkpoint blockade. | The findings suggest that integrating indole-rich foods or supplements may improve responses to immunotherapies, offering a potential nutritional strategy for patients. |
Frequently Asked Questions (FAQ)
What is the Aryl Hydrocarbon Receptor (AhR)?
AhR is a ligand-activated transcription factor that senses environmental and dietary molecules, particularly indoles produced from tryptophan metabolism. Activation of AhR influences immune cell development and function and has been linked to inflammation, tolerance and cancer immunity.
How do dietary indoles influence immunotherapy?
Food-derived indoles such as indole-3-carbinol (I3C) are converted into potent AhR agonists in the stomach. Supplementing an indole-poor diet with I3C restores physiologic AhR activation and enhances the efficacy of anti-PD1 therapy by supporting CD8⁺ T cell reinvigoration. Without these ligands, anti-PD1 treatment fails to fully reinvigorate progenitor-exhausted T cells and recruit NK cells.
Why was Norgen's Single Cell RNA Purification Kit used?
The study performed RNA-seq on small numbers of sorted CD8⁺ T cells. High-quality total RNA isolation is critical when working with rare cell populations; the Single Cell RNA Purification Kit (Cat.# 51800) from Norgen Biotek yields high-purity RNA, including microRNA, from as few as a single cell. This purity enabled accurate identification of AhR-dependent gene-expression changes.
Could diet modify immunotherapy outcomes in humans?
While this work was performed in mice, the gene signatures identified are enriched in human lung cancer patients responding to anti-PD1 therapy, suggesting translational relevance. Increasing dietary intake of cruciferous vegetables or indole supplements might enhance immunotherapy, but clinical trials are needed to validate these strategies.
- De Juan, A. et al. Physiological activation of Aryl hydrocarbon receptor by food-derived ligands is essential for the efficacy of anti-PD1 therapy. Nature Communications 16, 10598 (2025). DOI: 10.1038/s41467-025-66854-x.
